Published in Biomed Res Int on November 20, 2013
China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol (2015) 0.80
Ophthalmologic course of bilateral abducens nerve palsies after the treatment of idiopathic intracranial hypertension with venous sinus stenting. Neurol Sci (2015) 0.76
Assessment of Arterial Wall Enhancement for Differentiation of Parent Artery Disease from Small Artery Disease: Comparison between Histogram Analysis and Visual Analysis on 3-Dimensional Contrast-Enhanced T1-Weighted Turbo Spin Echo MR Images at 3T. Korean J Radiol (2017) 0.75
Endovascular Management of Intracranial Aneurysms: Advances in Stenting Techniques and Technology. J Cerebrovasc Endovasc Neurosurg (2015) 0.75
Evidence-based optimization of the management of intracranial atherosclerotic disease. Neurol Sci (2014) 0.75
Wingspan stenting can effectively prevent long-term strokes for patients with severe symptomatic atherosclerotic basilar stenosis. Interv Neuroradiol (2016) 0.75
Neuroprotection following acute ischemic stroke: efficacy of preconditioning and antioxidants. Neurol Sci (2014) 0.75
Management of intracranial atherosclerotic disease: current roles of medical therapy versus stent-assisted revascularization. Neurol Sci (2015) 0.75
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke (1995) 4.54
The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology (2008) 3.77
US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke (2007) 3.17
Global burden of intracranial atherosclerosis. Int J Stroke (2006) 2.98
A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke (2009) 2.80
A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke (2007) 2.70
Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol (1998) 2.12
Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke (2006) 1.83
Endovascular treatment of symptomatic intracranial stenosis with the Wingspan stent system and Gateway PTA balloon: a multicenter series of 60 patients with acute and midterm results. J Neurosurg (2011) 1.51
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg (2012) 1.45
Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke (2005) 1.25
Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke (2006) 1.21
Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol (2000) 1.15
Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke (2008) 1.14
Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13
The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery (2012) 1.12
Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery (2006) 1.10
Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms. Physiol Genomics (2012) 1.04
Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery (2012) 1.02
Intracranial stenting of subacute symptomatic atherosclerotic occlusion versus stenosis. Stroke (2011) 1.01
A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery. J Clin Neurosci (2012) 0.99
Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation. AJNR Am J Neuroradiol (2011) 0.99
Applications of stenting for intracranial atherosclerosis. Neurosurg Focus (2011) 0.96
Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology (1997) 0.96
Multicenter analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery (2012) 0.94
Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations. J Neuroimaging (2012) 0.93
A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis: A Controlled Clinical Trial. Cerebrovasc Dis Extra (2012) 0.92
Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis. Neurointervention (2013) 0.90
Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients. J Neurointerv Surg (2013) 0.89
Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency. Clin Neuroradiol (2012) 0.87
Standard of practice: endovascular treatment of intracranial atherosclerosis. J Neurointerv Surg (2012) 0.85
Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses : analysis of the INTRASTENT multicentric registry. Neuroradiology (2011) 0.84
Intracranial stenting for intracranial atherosclerotic disease: still much to learn. J Neurointerv Surg (2012) 0.84
Intravascular ultrasound: principles and cerebrovascular applications. AJNR Am J Neuroradiol (2010) 0.84
Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period. J Neurointerv Surg (2011) 0.84
Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis. Stroke (2013) 0.83
Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference. J Neurointerv Surg (2013) 0.82
Intracranial atheromatous disease treatment with the Wingspan stent system: evaluation of clinical, procedural outcome and restenosis rate in a single-center series of 21 consecutive patients with acute and mid-term results. Clin Neurol Neurosurg (2012) 0.81
Wingspan stent for high-grade symptomatic vertebrobasilar artery atherosclerotic stenosis. Cardiovasc Intervent Radiol (2011) 0.80
Usefulness of stent implantation for treatment of intracranial atherosclerotic stenoses. Neurointervention (2012) 0.80
Urgent recanalization with stenting for severe intracranial atherosclerosis after transient ischemic attack or minor stroke. J Korean Neurosurg Soc (2011) 0.79
Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients. Int J Stroke (2012) 0.79
Angioplasty and stenting for intracranial atherosclerotic stenosis with nitinol stent: factors affecting technical success and patient safety. Neurosurgery (2012) 0.78
Utility of intravascular ultrasound in intracranial and extracranial neurointerventions: experience at University at Buffalo Neurosurgery-Millard Fillmore Gates Circle Hospital. Neurosurg Focus (2012) 0.77
Update on intra-arterial chemotherapy for retinoblastoma. ScientificWorldJournal (2014) 1.15
Failure of the Pipeline Embolization Device in Posterior Communicating Artery Aneurysms Associated with a Fetal Posterior Cerebral Artery. Case Rep Vasc Med (2016) 1.01
Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage. Biomed Res Int (2014) 0.83
Response to: Comment on "Failure of the Pipeline Embolization Device in Posterior Communicating Artery Aneurysms Associated with a Fetal Posterior Cerebral Artery". Case Rep Vasc Med (2017) 0.75
Endovascular intervention for acute ischemic stroke in light of recent trials. ScientificWorldJournal (2014) 0.75